Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs

This publication has 17 references indexed in Scilit:

• Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever
  Vaccine, 2000
• Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus
  Published by Elsevier ,1999
• Virus Taxonomy – 1999
  Archiv für die gesamte Virusforschung, 1999
• An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV)
  Published by Elsevier ,1999
• Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever.
  Journal of General Virology, 1997
• Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge
  Journal of General Virology, 1996
• Potency control of modified live viral vaccines for veterinary use
  Vaccine, 1996
• The protective value of vaccine-induced neutralising antibody titres in swine fever
  Veterinary Microbiology, 1988
• Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis
  Veterinary Microbiology, 1986
• Studies on the Pathogenesis of Hog Cholera¹
  Zentralblatt für Veterinärmedizin Reihe B, 1973